13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q1 2022. See the latest, Q2 2026 →
Reported value
$405.10B
−11% on the quarter before
Positions
440
29 new · 29 sold out
Top 10
28.1%
of the value
Est. gain
−$29.32B
on stocks held all quarter
Est. return
−7.3%
on those stocks since Q4 2021
Positions as of Mar 31, 2022, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 46% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2021. Striped tiles are options.
Largest buys
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- General Electric Co~$2.12BAdded · 1.1% → 1.7%+23,155,612 shares
- Amazon~$2.08BAdded · 3.4% → 4.2%+639,231 shares
- Schwab Charles Corp~$1.94BAdded · 0.0% → 0.5%+22,953,375 shares
- Apple~$1.63BAdded · 1.2% → 1.7%+9,354,484 shares
- EPAM Systems~$1.42BAdded · 0.3% → 0.5%+4,798,503 shares
- Berkshire Hathaway Inc Del~$1.40BAdded · 0.1% → 0.5%+3,964,679 shares
- Morgan Stanley~$1.17BAdded · 0.3% → 0.6%+13,367,310 shares
- Raytheon Technologies Corp~$816.1MAdded · 1.1% → 1.7%+8,237,529 shares
- Philip Morris Intl Inc~$790.7MAdded · 1.2% → 1.5%+8,417,407 shares
- Unitedhealth Group Inc~$756.0MAdded · 2.0% → 2.4%+1,482,338 shares
Largest sells
Since Q4 2021, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Gilead Sciences Inc~$3.04BCut · 1.7% → 0.8%−51,205,602 shares
- Netflix~$2.69BCut · 3.5% → 1.7%−7,180,030 shares
- Microsoft~$1.99BCut · 6.9% → 6.6%−6,444,231 shares
- Home Depot Inc~$1.46BCut · 1.3% → 0.6%−4,878,376 shares
- Csx Corp~$1.17BCut · 0.9% → 0.7%−31,241,194 shares
- Chevron Corp New~$1.11BCut · 0.6% → 0.7%−6,823,983 shares
- Cenovus Energy Inc~$1.11BCut · 0.5% → 0.5%−66,651,959 shares
- Accenture Plc Ireland~$939.9MCut · 0.9% → 0.6%−2,787,054 shares
- Alphabet~$929.3MCut · 1.9% → 1.8%−332,726 shares
- Amgen Inc~$901.1MCut · 1.1% → 1.1%−3,726,355 shares
Holdings
As of Mar 31, 2022. Changes are in shares against Dec 31, 2021, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −6.9% · price −8.3% | 6.6% | $26.65B | −$2.42B | ||||||||
| AmazonCOM · shares +14% · price −2.2% | 4.2% | $17.00B | −$340.2M | ||||||||
| BroadcomCOM · shares −2.8% · price −5.4% | 3.4% | $13.96B | −$792.1M | ||||||||
| Unitedhealth Group IncCOM · shares +8.3% · price +1.6% | 2.4% | $9.83B | +$139.4M | ||||||||
| Abbott LabsCOM · shares −4.1% · price −15.9% | 2.4% | $9.55B | −$1.81B | ||||||||
| AlphabetCAP STK CL A · shares −9.3% · price −4.0% | 2.0% | $8.21B | −$341.5M | ||||||||
| Comcast Corp NewCL A · shares −0.5% · price −7.0% | 1.8% | $7.27B | −$545.0M | ||||||||
| AlphabetCAP STK CL C · shares −11% · price −3.5% | 1.8% | $7.27B | −$261.6M | ||||||||
| Canadian Nat Res LtdCOM · shares −4.6% · price +46.5% | 1.8% | $7.16B | +$2.28B | ||||||||
| General Electric CoCOM NEW · shares +43% · price −3.1% | 1.7% | $7.06B | −$160.3M | ||||||||
| NetflixCOM · shares −28% · price −37.8% | 1.7% | $7.04B | −$4.28B | ||||||||
| AppleCOM · shares +32% · price −1.7% | 1.7% | $6.79B | −$87.4M | ||||||||
| Raytheon Technologies CorpCOM · shares +14% · price +15.1% | 1.7% | $6.72B | +$775.5M | ||||||||
| MetaCL A · shares −0.2% · price −33.9% | 1.6% | $6.65B | −$3.41B | ||||||||
| Philip Morris Intl IncCOM · shares +15% · price −1.1% | 1.5% | $6.19B | −$60.9M | ||||||||
| Thermo Fisher Scientific IncCOM · shares −8.1% · price −11.5% | 1.3% | $5.13B | −$665.5M | ||||||||
| MastercardCL A · shares +3.4% · price −0.5% | 1.2% | $5.03B | −$26.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares +4.5% · price −13.9% | 1.2% | $4.99B | −$771.5M | ||||||||
| MercadoLibreCOM · shares −9.8% · price −11.8% | 1.2% | $4.98B | −$665.1M | ||||||||
| Amgen IncCOM · shares −17% · price +7.5% | 1.1% | $4.46B | +$310.6M | ||||||||
| Linde PlcSHS · shares +4.2% · price −7.8% | 1.1% | $4.38B | −$354.4M | ||||||||
| Toronto Dominion Bk OntCOM NEW · shares +2.2% · price +3.5% | 1.0% | $4.05B | +$133.9M | ||||||||
| Carrier GlobalCOM · shares +14% · price −15.4% | 0.89% | $3.62B | −$581.3M | ||||||||
| General Mtrs CoCOM · shares −15% · price −25.4% | 0.88% | $3.55B | −$1.21B | ||||||||
| Vale S ASPONSORED ADS · shares −9.4% · price +42.6% | 0.87% | $3.52B | +$1.05B | ||||||||
| Total · 440 positions | 100% | $405.10B | −$29.32B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2021 to Q1 2022: 408 stocks held throughout, down $29.32B (−7.3%).
- Canadian Nat Res Ltd+$2.28B+47%
- Baker Hughes+$1.07B+51%
- Vale S A+$1.05B+43%
- Eog Res Inc+$868.4M+34%
- Raytheon Technologies Corp+$775.5M+15%
- Shopify Inc−$1.48B−51%
- Abbott Labs−$1.81B−16%
- Microsoft−$2.42B−8%
- Meta−$3.41B−34%
- Netflix−$4.28B−38%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |